WestCoastSummit WestCoastSummit

West Coast Diagnostics Summit

ACLA and AdvaMedDx have teamed up to sponsor a first-of-its-kind diagnostic summit this fall in San Diego. 

shutterstock_193931348 shutterstock_193931348

ACLA Applauds CMS Decision to Delay New Payment System, Evaluating Final PAMA Rule

shutterstock_193931348 shutterstock_193931348

House Agriculture-FDA Appropriations Bill Includes Report Language Directing FDA Suspend Efforts to Finalize LDT Guidance

shutterstock_193931348 shutterstock_193931348

Bipartisan House Ways and Means Committee Letter Sent to CMS

Health Subcommittee Chairman Tiberi, Representatives Meehan and Pascrell sent a bipartisan letter urging CMS to delay PAMA changes to the Clinical Laboratory Fee Schedule.

Read More »
JoinACLA_banner JoinACLA_banner


Learn about the benefits of joining the nation’s leading advocacy organization for clinical laboratories.

pama slider pama slider

The Protecting Access to Medicare Act of 2014

Big changes are coming to how Medicare pays for clinical lab services – here’s everything your lab needs to know about the new law. 

Learn More »

View all news & updates » Recent News & Updates

View all news & updates »

Policy Issues

  • Reimbursement and Coverage

    Medicare cuts to clinical labs threaten jobs, stifle innovation, and put patient access to vital lab tests at risk.

    Continue Reading »

  • Laboratory Developed Tests

    FDA regulation of laboratory-developed tests (LDTs) is duplicative, outside of FDA jurisdiction, and would negatively impact patient access to vital lab tests.

    Continue Reading »

  • IOAS Exception

    Self-referral leads to over-utilization, mistreated patients, and billions of wasted Medicare dollars. It’s time to close the loophole.

    Continue Reading »

View all policy issues »